Consensus Statement on the Use of Intravenous Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke by the Chinese Stroke Therapy Expert Panel

Author:

Xu An-Ding1,Wang Yong-Jun2,Wang David Z3,

Affiliation:

1. Department of Neurology; The First Affiliated Hospital; Jinan University Guangzhou; Guangzhou; China

2. Department of Neurology; Beijing Tiantan Hospital; Capital Medical University; Beijing; China

3. INI Stroke Network; OSF Healthcare System; Department of Neurology; University of Illinois College of Medicine At Peoria; IL; USA

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Reference40 articles.

1. Chinese consensus expert panel for intravenous recombinant tissue plasminogen activator for acute ischemic stroke. Consensus statement on intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke;Chin J Intern Med,2006

2. Tissue plasminogen activator for acute ischemic stroke;The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N Engle J Med,1995

3. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials;Hacke;Lancet,2004

4. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study;Wahlgren;Lancet,2007

5. Thrombolysis with intravenous recombinant tissue plasminogen Activator 3 to 4.5 h after acute ischemic stroke in China;Liao;Stroke,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3